dN/dS ratio for all SARS-CoV-2 open reading frames, ORF1ab and spike for the <i>in vitro</i> continually passaged SARS-CoV-2. by Agnieszka M. Szemiel (10196243)

Subjects:

DN1 and DN2 cells are preferentially increased by TSLP in FTOC and decreased in TSLPRFTOC by Qi Jiang (33521)

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

“…</b> RT-qPCR of WT1, p<0.05(*), vFLIP(ns), LANA, p<0.0001(****), K8.1, p<0.0001(****), and BCL2 p<0.05(*) in the setting of WT1 knockdown in ISLK BAC-16 with WT1 siRNA in comparison to a control siRNA using two-sided, unpaired student’s t-tests. …”

SARS-CoV-2 inhibition by MAP30 and Momordin. by Norman R. Watts (1964959)

MET knockdown decreases EGFR activation and does not influence EGFR expression. by Karolin Ebert (7434713)

Schematic for measuring <i>D</i> and <i>D</i>′ values. by Hong Zhang (25820)

“…The measured <i>I</i>_s decreases following a power-law trend as <i>β</i> and <i>D</i> increase, with weathering reducing the sensitivity of <i>I</i>_s to <i>β</i> but not significantly altering its sensitivity to <i>D</i>. …”

Heterozygous deletion of <i>ERG251-A</i> leads to a transcriptional response in filamentation regulation. by Xin Zhou (54275)

Postnatal decrease in PV+ cortical interneurons in Fgfr1 mutant mice. by Karen Müller Smith (613941)

“…Immunostaining for GFAP, Neun, Ng2, Olig2 and GFP in cortex of adult TgFgfr1-GFP mice (<b>D, E, F</b>). …”

Decreased expression of DYRK2 in paraffin-embedded colorectal cancer tissues and advanced colorectal cancer. by Haiyan Yan (2993082)

The functional half-life of WNV decreases in the presence of virus-specific antibody. by Kimberly A. Dowd (129927)

Rab7A decreases BST2 cell surface expression and is required for Vpu-induced BST2 cell surface downregulation. by Marina Caillet (198168)

“…<p>(<b>A</b>–<b>B</b>) Rab7A decreases BST2 cell surface expression. …”

Inhibition of VEGF-A gene synthesis decreased ranibizumab and aflibercept mediated CCL2 CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)

Cephalometric measurement points. by Lijuan Liu (136685)

(A) CaMKII inhibition by KN-93 or AIP, or calmodulin inhibition by W-7 decreases O₂ consumption in SANC suspension (n = 5 for each drug), (B) AIP decreases mitochondrial flavoprotein fluorescence in single SANC (representative example), indicating a net reduction of flavoprotein pool. by Yael Yaniv (162548)

The VPS C846G mutation decreases the stability of VPS11 protein. by Jinglan Zhang (401545)

Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study by Jilles M. Fermont (3746068)

“…In total, 291 of 714 individuals experienced 762 hospitalised AECOPD during five-year follow up. Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. …”

Decreased levels of vitamin D3 and supplementation with 1,25-dihydroxyvitamin D3-glycoside on performance, carcass yield and bone quality in broilers by Osvanira dos Santos Alves (5555027)

“…Seven-d-old male chickens Cobb500® were distributed in a randomized design with six treatments: a control diet with inclusion of vitamin D3 in the premix, without supplementation of 1,25(OH)2D3-glycoside, and five diets with decreased levels of vitamin D3 (100%, 75%, 50%, 25% and 0% about the control) plus the addition of 1,25(OH)2D3-glycoside, 50g ton-1 of diet. …”

Aspirin-Triggered Resolvin D1 Attenuated IL-1β-induced Cytokine/Chemokine Secretion. by Ruan Cox Jr. (789575)

The point mutation of <i>ERG251</i> leads to the partial dysfunction of <i>ERG251</i> causing acquisition of azole tolerance. by Xin Zhou (54275)